Financials

  • Market Capitalization 1.53 B
  • Employee 435
  • Founded 2005
  • CEO N/A
  • Website www.xerispharma.com
  • Headquarter Illinois, United States
  • FIGI BBG012V1MG52
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
Rapporto prezzo/fatturato
4.65

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2146
BCAX
Bicara Therapeutics Inc. - Common Stock
24.83 USD+0.40%+2.22%-7.63%+71.95%1.64 B USD
2152
FBRX
Forte Biosciences, Inc. - Common Stock
76.99 USD0.00%+0.06%+0.50%+162.32%1.63 B USD
2179
TYRA
Tyra Biosciences, Inc. - Common Stock
25.32 USD-3.10%-4.60%-19.16%+76.57%1.51 B USD
2187
LBRX
LB Pharmaceuticals Inc - Common Stock
47.20 USD-1.44%+0.23%+34.32%+148.42%1.52 B USD

Notizie